Figure 2

Impacts of iguratimod (IGU) on submandibular gland (A) and spleen (B) indices in non-obese diabetic (NOD) mice. Model vs. normal, ^#p < 0.05, ^##p < 0.01. IGU 10 mg/kg and IGU 30 mg/kg vs. model, *p < 0.05, **p < 0.01. IGU 30 mg/kg vs. IGU 10 mg/kg, ^△p < 0.05, ^△△p < 0.01. IGU 10 mg/kg (8 weeks) vs. IGU 10 mg/kg (5 weeks). IGU 30 mg/kg (8 weeks) vs. IGU 30 mg/kg (5 weeks), ^✫p < 0.05, ^✫✫p < 0.01.